Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus


Enocsson H., Wirestam L., Dahle C., Padyukov L., Jonsen A., Urowitz M. B. , ...Daha Fazla

JOURNAL OF AUTOIMMUNITY, cilt.106, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objective: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus (SLE). Herein, we evaluated suPAR as a predictor of future organ damage in recent-onset SLE.